HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

siltuximab

a chimeric anti-interleukin-6 antibody for treatment of multiple myeloma and renal cell carcinoma
Also Known As:
CLLB8; CNTO 328 monoclonal antibody; CNTO-328; Sylvant; cClB8 monoclonal antibody; monoclonal antibody CNTO 328; monoclonal antibody CNTO-328; monoclonal antibody CNTO328
Networked: 115 relevant articles (19 outcomes, 41 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. van Rhee, Frits: 12 articles (01/2022 - 08/2010)
2. Qi, Ming: 11 articles (01/2019 - 08/2010)
3. van de Velde, Helgi: 10 articles (10/2015 - 05/2013)
4. Reddy, Manjula: 10 articles (10/2015 - 09/2011)
5. Kurzrock, Razelle: 9 articles (07/2020 - 08/2010)
6. Casper, Corey: 8 articles (01/2021 - 08/2010)
7. Qin, Xiang: 8 articles (01/2019 - 08/2010)
8. Bandekar, Rajesh: 7 articles (01/2019 - 01/2014)
9. Puchalski, Thomas A: 7 articles (05/2015 - 06/2013)
10. Voorhees, Peter M: 6 articles (03/2020 - 11/2007)

Related Diseases

1. Castleman Disease (Castleman's Disease)
2. Multiple Myeloma
3. Neoplasms (Cancer)
4. COVID-19
5. Multi-centric Castleman's Disease

Related Drugs and Biologics

1. Interleukin-6 (Interleukin 6)
2. tocilizumab (atlizumab)
3. Monoclonal Antibodies
4. Bortezomib (Velcade)
5. sarilumab
6. Interleukin-6 Inhibitors
7. Interleukin 1 Receptor Antagonist Protein (Anakinra)
8. Interleukin-6 Receptors (Interleukin 6 Receptor)
9. Dexamethasone (Maxidex)
10. Interleukins

Related Therapies and Procedures

1. Therapeutics
2. Aftercare (After-Treatment)
3. Castration
4. Drug Therapy (Chemotherapy)
5. Investigational Therapies (Experimental Therapy)